{"date":"2026-05-29","count":112,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-4178-2026-05-29-2015-134amza","company_id":"4178","company":"永笙-KY","market":"上市","industry":"生技醫療","date":"2026-05-29","time":"20:15:00","subject":"代重要子公司StemCyte, Inc. (美國永生公司)公告董事異動","clause":"第6款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：永笙-KY（4178），2026-05-29 20:15，「代重要子公司StemCyte, Inc. (美國永生公司)公告董事異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4178-2026-05-29-2014-2c4x7p","company_id":"4178","company":"永笙-KY","market":"上市","industry":"生技醫療","date":"2026-05-29","time":"20:14:20","subject":"代重要子公司台灣永生公告董事會代行股東會職權解除新任董事競業禁止之限制","clause":"第21款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：永笙-KY（4178），2026-05-29 20:14，「代重要子公司台灣永生公告董事會代行股東會職權解除新任董事競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4178-2026-05-29-2013-1fhyydq","company_id":"4178","company":"永笙-KY","market":"上市","industry":"生技醫療","date":"2026-05-29","time":"20:13:26","subject":"代重要子公司台灣永生公告董事會決議解除經理人競業禁止之限制","clause":"第21款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：永笙-KY（4178），2026-05-29 20:13，「代重要子公司台灣永生公告董事會決議解除經理人競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4178-2026-05-29-2012-ik5ijr","company_id":"4178","company":"永笙-KY","market":"上市","industry":"生技醫療","date":"2026-05-29","time":"20:12:15","subject":"代重要子公司台灣永生公告總經理異動","clause":"第6款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：永笙-KY（4178），2026-05-29 20:12，「代重要子公司台灣永生公告總經理異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4190-2026-05-29-2012-9769qc","company_id":"4190","company":"佐登-KY","market":"上市","industry":"生技醫療","date":"2026-05-29","time":"20:12:04","subject":"公告本公司董事會選任董事長","clause":"第6款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：佐登-KY（4190），2026-05-29 20:12，「公告本公司董事會選任董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4190-2026-05-29-2011-114uj4h","company_id":"4190","company":"佐登-KY","market":"上市","industry":"生技醫療","date":"2026-05-29","time":"20:11:41","subject":"本公司審計委員會及薪酬委員會異動","clause":"第6款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：佐登-KY（4190），2026-05-29 20:11，「本公司審計委員會及薪酬委員會異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4178-2026-05-29-2011-ret8fr","company_id":"4178","company":"永笙-KY","market":"上市","industry":"生技醫療","date":"2026-05-29","time":"20:11:18","subject":"代重要子公司台灣永生公告董事會選任董事長","clause":"第6款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：永笙-KY（4178），2026-05-29 20:11，「代重要子公司台灣永生公告董事會選任董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4178-2026-05-29-2010-hjs1lk","company_id":"4178","company":"永笙-KY","market":"上市","industry":"生技醫療","date":"2026-05-29","time":"20:10:15","subject":"代重要子公司台灣永生公告法人董事改派代表人暨三分之一以上董事發生變動","clause":"第6款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：永笙-KY（4178），2026-05-29 20:10，「代重要子公司台灣永生公告法人董事改派代表人暨三分之一以上董事發生變動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4178-2026-05-29-2009-iclhus","company_id":"4178","company":"永笙-KY","market":"上市","industry":"生技醫療","date":"2026-05-29","time":"20:09:35","subject":"代重要子公司台灣永生公告董事會代行股東會職權重要決議事項","clause":"第18款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：永笙-KY（4178），2026-05-29 20:09，「代重要子公司台灣永生公告董事會代行股東會職權重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4178-2026-05-29-2008-on65kl","company_id":"4178","company":"永笙-KY","market":"上市","industry":"生技醫療","date":"2026-05-29","time":"20:08:37","subject":"公告董事會決議解除經理人競業禁止之限制","clause":"第21款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：永笙-KY（4178），2026-05-29 20:08，「公告董事會決議解除經理人競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4190-2026-05-29-2007-kl54d2","company_id":"4190","company":"佐登-KY","market":"上市","industry":"生技醫療","date":"2026-05-29","time":"20:07:45","subject":"公告本公司115年股東常會改選第六屆董事(含獨立董事)","clause":"第6款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：佐登-KY（4190），2026-05-29 20:07，「公告本公司115年股東常會改選第六屆董事(含獨立董事)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4178-2026-05-29-2007-83s47v","company_id":"4178","company":"永笙-KY","market":"上市","industry":"生技醫療","date":"2026-05-29","time":"20:07:39","subject":"公告本公司新任共同執行長","clause":"第6款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：永笙-KY（4178），2026-05-29 20:07，「公告本公司新任共同執行長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4178-2026-05-29-2006-1ifbulk","company_id":"4178","company":"永笙-KY","market":"上市","industry":"生技醫療","date":"2026-05-29","time":"20:06:26","subject":"公告本公司董事會推選副董事長","clause":"第6款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：永笙-KY（4178），2026-05-29 20:06，「公告本公司董事會推選副董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4178-2026-05-29-2005-15q4hue","company_id":"4178","company":"永笙-KY","market":"上市","industry":"生技醫療","date":"2026-05-29","time":"20:05:24","subject":"公告本公司改派法人董事代表人","clause":"第6款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：永笙-KY（4178），2026-05-29 20:05，「公告本公司改派法人董事代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4178-2026-05-29-2003-lewzru","company_id":"4178","company":"永笙-KY","market":"上市","industry":"生技醫療","date":"2026-05-29","time":"20:03:45","subject":"公告本公司2026年股東常會重要決議事項","clause":"第18款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：永笙-KY（4178），2026-05-29 20:03，「公告本公司2026年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4190-2026-05-29-1956-15e1v8f","company_id":"4190","company":"佐登-KY","market":"上市","industry":"生技醫療","date":"2026-05-29","time":"19:56:27","subject":"本公司115年股東常會重要決議事項","clause":"第18款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：佐登-KY（4190），2026-05-29 19:56，「本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6734-2026-05-29-1914-tqjfcj","company_id":"6734","company":"安盛生","market":"興櫃","industry":"生技醫療","date":"2026-05-29","time":"19:14:46","subject":"公告本公司115年4月份自結財務報告之負債比率、流動比率、速動比率、預估未來三個月現金收支情形及銀行可使用融資額度情形","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安盛生（6734），2026-05-29 19:14，「公告本公司115年4月份自結財務報告之負債比率、流動比率、速動比率、預估未來三個月現金收支情形及銀行可使用融資額度情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4905-2026-05-29-1822-5aq1a1","company_id":"4905","company":"台聯電","market":"上櫃","industry":"生技醫療","date":"2026-05-29","time":"18:22:33","subject":"代重要子公司欣德芮(股)公司公告召開115年股東常會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台聯電（4905），2026-05-29 18:22，「代重要子公司欣德芮(股)公司公告召開115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1752-2026-05-29-1818-1vhu1xi","company_id":"1752","company":"南光","market":"上市","industry":"生技醫療","date":"2026-05-29","time":"18:18:06","subject":"公告本公司發言人異動","clause":"第8款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：南光（1752），2026-05-29 18:18，「公告本公司發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6469-2026-05-29-1758-uork9d","company_id":"6469","company":"大樹","market":"上櫃","industry":"生技醫療","date":"2026-05-29","time":"17:58:06","subject":"公告本公司股東常會解除新任董事及其代表人競業行為之限制","clause":"第21款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：大樹（6469），2026-05-29 17:58，「公告本公司股東常會解除新任董事及其代表人競業行為之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6469-2026-05-29-1757-10lydzg","company_id":"6469","company":"大樹","market":"上櫃","industry":"生技醫療","date":"2026-05-29","time":"17:57:35","subject":"公告本公司審計委員會及薪資報酬委員會任期屆滿改選","clause":"第6款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：大樹（6469），2026-05-29 17:57，「公告本公司審計委員會及薪資報酬委員會任期屆滿改選」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6469-2026-05-29-1756-s0kpz3","company_id":"6469","company":"大樹","market":"上櫃","industry":"生技醫療","date":"2026-05-29","time":"17:56:59","subject":"公告本公司董事會推選董事長","clause":"第6款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：大樹（6469），2026-05-29 17:56，「公告本公司董事會推選董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6469-2026-05-29-1756-1hvkc3c","company_id":"6469","company":"大樹","market":"上櫃","industry":"生技醫療","date":"2026-05-29","time":"17:56:25","subject":"公告本公司115年股東常會全面改選董事","clause":"第6款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：大樹（6469），2026-05-29 17:56，「公告本公司115年股東常會全面改選董事」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6469-2026-05-29-1755-1jb8ii5","company_id":"6469","company":"大樹","market":"上櫃","industry":"生技醫療","date":"2026-05-29","time":"17:55:27","subject":"公告本公司115年股東常會重要決議事項","clause":"第18款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：大樹（6469），2026-05-29 17:55，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6469-2026-05-29-1754-vjdw3j","company_id":"6469","company":"大樹","market":"上櫃","industry":"生技醫療","date":"2026-05-29","time":"17:54:58","subject":"代重要子公司百林物流股份有限公司公告114年度盈餘分配案","clause":"第14款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：大樹（6469），2026-05-29 17:54，「代重要子公司百林物流股份有限公司公告114年度盈餘分配案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6469-2026-05-29-1754-10v1qqw","company_id":"6469","company":"大樹","market":"上櫃","industry":"生技醫療","date":"2026-05-29","time":"17:54:31","subject":"代重要子公司常春藤生技股份有限公司公告114年度盈餘分配案","clause":"第14款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：大樹（6469），2026-05-29 17:54，「代重要子公司常春藤生技股份有限公司公告114年度盈餘分配案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4128-2026-05-29-1749-gbjez6","company_id":"4128","company":"中天","market":"上櫃","industry":"生技醫療","date":"2026-05-29","time":"17:49:56","subject":"代重要子公司棉花田生機園地(股)公司公告115年股東常會重要決議事項","clause":"第18款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：中天（4128），2026-05-29 17:49，「代重要子公司棉花田生機園地(股)公司公告115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4128-2026-05-29-1749-1l94isd","company_id":"4128","company":"中天","market":"上櫃","industry":"生技醫療","date":"2026-05-29","time":"17:49:34","subject":"代重要子公司棉花田生機園地(股)公司公告115年股東常會決議解除董事競業禁止之限制事宜","clause":"第21款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：中天（4128），2026-05-29 17:49，「代重要子公司棉花田生機園地(股)公司公告115年股東常會決議解除董事競業禁止之限制事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4726-2026-05-29-1739-1x5drlc","company_id":"4726","company":"永昕","market":"上櫃","industry":"生技醫療","date":"2026-05-29","time":"17:39:45","subject":"公告本公司限制員工權利新股註銷完成變更登記","clause":"第36款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：永昕（4726），2026-05-29 17:39，「公告本公司限制員工權利新股註銷完成變更登記」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4735-2026-05-29-1728-yj849u","company_id":"4735","company":"豪展","market":"上櫃","industry":"生技醫療","date":"2026-05-29","time":"17:28:35","subject":"公告本公司董事長訂定民國115年第1季盈餘之除息基準日","clause":"第14款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：豪展（4735），2026-05-29 17:28，「公告本公司董事長訂定民國115年第1季盈餘之除息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4905-2026-05-29-1709-l4w7ec","company_id":"4905","company":"台聯電","market":"上櫃","industry":"生技醫療","date":"2026-05-29","time":"17:09:22","subject":"代重要孫公司福億通訊(股)公司公告董事決定發放股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台聯電（4905），2026-05-29 17:09，「代重要孫公司福億通訊(股)公司公告董事決定發放股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4905-2026-05-29-1708-1ex80kl","company_id":"4905","company":"台聯電","market":"上櫃","industry":"生技醫療","date":"2026-05-29","time":"17:08:45","subject":"代重要子公司價值投資(股)公司公告董事決定發放股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台聯電（4905），2026-05-29 17:08，「代重要子公司價值投資(股)公司公告董事決定發放股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4905-2026-05-29-1707-1jw1hca","company_id":"4905","company":"台聯電","market":"上櫃","industry":"生技醫療","date":"2026-05-29","time":"17:07:51","subject":"代重要子公司聯創投資(股)公司公告董事決定發放股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台聯電（4905），2026-05-29 17:07，「代重要子公司聯創投資(股)公司公告董事決定發放股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6665-2026-05-29-1702-k9tiq9","company_id":"6665","company":"康聯生醫","market":"興櫃","industry":"生技醫療","date":"2026-05-29","time":"17:02:18","subject":"代重要子公司康儀科技股份有限公司公告除息基準日","clause":"第31款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：康聯生醫（6665），2026-05-29 17:02，「代重要子公司康儀科技股份有限公司公告除息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6665-2026-05-29-1702-jyqeqq","company_id":"6665","company":"康聯生醫","market":"興櫃","industry":"生技醫療","date":"2026-05-29","time":"17:02:05","subject":"公告本公司董事長訂定除息基準日及調整配息率","clause":"第31款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：康聯生醫（6665），2026-05-29 17:02，「公告本公司董事長訂定除息基準日及調整配息率」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6665-2026-05-29-1701-1wba1yj","company_id":"6665","company":"康聯生醫","market":"興櫃","industry":"生技醫療","date":"2026-05-29","time":"17:01:54","subject":"本公司115年股東常會通過解除董事及其代表人競業禁止限制案","clause":"第22款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：康聯生醫（6665），2026-05-29 17:01，「本公司115年股東常會通過解除董事及其代表人競業禁止限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6665-2026-05-29-1701-1bc3tuf","company_id":"6665","company":"康聯生醫","market":"興櫃","industry":"生技醫療","date":"2026-05-29","time":"17:01:41","subject":"公告本公司董事會委任第四屆薪資報酬委員會委員","clause":"第6款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：康聯生醫（6665），2026-05-29 17:01，「公告本公司董事會委任第四屆薪資報酬委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6665-2026-05-29-1701-3dirn2","company_id":"6665","company":"康聯生醫","market":"興櫃","industry":"生技醫療","date":"2026-05-29","time":"17:01:29","subject":"公告本公司第四屆審計委員會成員","clause":"第6款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：康聯生醫（6665），2026-05-29 17:01，「公告本公司第四屆審計委員會成員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6665-2026-05-29-1701-s0kpz3","company_id":"6665","company":"康聯生醫","market":"興櫃","industry":"生技醫療","date":"2026-05-29","time":"17:01:14","subject":"公告本公司董事會推選董事長","clause":"第6款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：康聯生醫（6665），2026-05-29 17:01，「公告本公司董事會推選董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6861-2026-05-29-1657-123nsb6","company_id":"6861","company":"睿生光電","market":"上市","industry":"生技醫療","date":"2026-05-29","time":"16:57:15","subject":"公告本公司訂定民國115年發放現金股利基準日","clause":"第14款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：睿生光電（6861），2026-05-29 16:57，「公告本公司訂定民國115年發放現金股利基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6861-2026-05-29-1656-cobe39","company_id":"6861","company":"睿生光電","market":"上市","industry":"生技醫療","date":"2026-05-29","time":"16:56:56","subject":"公告本公司115年股東常會重要決議","clause":"第18款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：睿生光電（6861），2026-05-29 16:56，「公告本公司115年股東常會重要決議」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6665-2026-05-29-1653-zhkfod","company_id":"6665","company":"康聯生醫","market":"興櫃","industry":"生技醫療","date":"2026-05-29","time":"16:53:48","subject":"公告本公司115年股東常會全面改選董事當選名單","clause":"第6款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：康聯生醫（6665），2026-05-29 16:53，「公告本公司115年股東常會全面改選董事當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6665-2026-05-29-1653-1jb8ii5","company_id":"6665","company":"康聯生醫","market":"興櫃","industry":"生技醫療","date":"2026-05-29","time":"16:53:26","subject":"公告本公司115年股東常會重要決議事項","clause":"第15款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：康聯生醫（6665），2026-05-29 16:53，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6637-2026-05-29-1636-tetww8","company_id":"6637","company":"醫影","market":"上櫃","industry":"生技醫療","date":"2026-05-29","time":"16:36:35","subject":"公告本公司115年股東常會通過解除董事競業禁止限制","clause":"第21款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：醫影（6637），2026-05-29 16:36，「公告本公司115年股東常會通過解除董事競業禁止限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6637-2026-05-29-1636-peusgi","company_id":"6637","company":"醫影","market":"上櫃","industry":"生技醫療","date":"2026-05-29","time":"16:36:07","subject":"公告本公司第四屆審計委員會委員","clause":"第6款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：醫影（6637），2026-05-29 16:36，「公告本公司第四屆審計委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6637-2026-05-29-1635-1x7tihs","company_id":"6637","company":"醫影","market":"上櫃","industry":"生技醫療","date":"2026-05-29","time":"16:35:34","subject":"公告本公司選任新任董事長","clause":"第6款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：醫影（6637），2026-05-29 16:35，「公告本公司選任新任董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6637-2026-05-29-1635-6c9poe","company_id":"6637","company":"醫影","market":"上櫃","industry":"生技醫療","date":"2026-05-29","time":"16:35:14","subject":"本公司115年股東常會全面改選董事(含獨立董事)當選名單","clause":"第6款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：醫影（6637），2026-05-29 16:35，「本公司115年股東常會全面改選董事(含獨立董事)當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6637-2026-05-29-1634-1jb8ii5","company_id":"6637","company":"醫影","market":"上櫃","industry":"生技醫療","date":"2026-05-29","time":"16:34:39","subject":"公告本公司115年股東常會重要決議事項","clause":"第18款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：醫影（6637），2026-05-29 16:34，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4133-2026-05-29-1625-xgiec","company_id":"4133","company":"亞諾法","market":"上市","industry":"生技醫療","date":"2026-05-29","time":"16:25:22","subject":"公告本公司審計委員會、薪資報酬委員會、風險管理委員會及永續發展委員會委員任期屆滿及新任名單","clause":"第6款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：亞諾法（4133），2026-05-29 16:25，「公告本公司審計委員會、薪資報酬委員會、風險管理委員會及永續發展委員會委員任期屆滿及新任名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7713-2026-05-29-1624-9769qc","company_id":"7713","company":"威力德生醫","market":"上櫃","industry":"生技醫療","date":"2026-05-29","time":"16:24:56","subject":"公告本公司董事會選任董事長","clause":"第6款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：威力德生醫（7713），2026-05-29 16:24，「公告本公司董事會選任董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7713-2026-05-29-1624-404p2v","company_id":"7713","company":"威力德生醫","market":"上櫃","industry":"生技醫療","date":"2026-05-29","time":"16:24:25","subject":"公告本公司第二屆審計委員會委員","clause":"第6款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：威力德生醫（7713），2026-05-29 16:24，「公告本公司第二屆審計委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7713-2026-05-29-1623-1rb72wr","company_id":"7713","company":"威力德生醫","market":"上櫃","industry":"生技醫療","date":"2026-05-29","time":"16:23:51","subject":"公告本公司115年股東常會通過解除本公司新任董事及其代表人競業禁止之限制案","clause":"第21款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：威力德生醫（7713），2026-05-29 16:23，「公告本公司115年股東常會通過解除本公司新任董事及其代表人競業禁止之限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7713-2026-05-29-1623-8z46pl","company_id":"7713","company":"威力德生醫","market":"上櫃","industry":"生技醫療","date":"2026-05-29","time":"16:23:09","subject":"公告本公司115年股東常會全面改選董事(含獨立董事)當選名單暨董事變動達三分之一","clause":"第6款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：威力德生醫（7713），2026-05-29 16:23，「公告本公司115年股東常會全面改選董事(含獨立董事)當選名單暨董事變動達三分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7713-2026-05-29-1622-1jb8ii5","company_id":"7713","company":"威力德生醫","market":"上櫃","industry":"生技醫療","date":"2026-05-29","time":"16:22:43","subject":"公告本公司115年股東常會重要決議事項","clause":"第18款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：威力德生醫（7713），2026-05-29 16:22，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6534-2026-05-29-1622-17itdjb","company_id":"6534","company":"正瀚-創","market":"上市","industry":"生技醫療","date":"2026-05-29","time":"16:22:35","subject":"公告本公司第一次買回庫藏股執行完畢","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：正瀚-創（6534），2026-05-29 16:22，「公告本公司第一次買回庫藏股執行完畢」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6730-2026-05-29-1612-1ro4qiv","company_id":"6730","company":"常廣","market":"上櫃","industry":"生技醫療","date":"2026-05-29","time":"16:12:59","subject":"公告本公司第一屆永續發展委員會任期屆滿","clause":"第6款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：常廣（6730），2026-05-29 16:12，「公告本公司第一屆永續發展委員會任期屆滿」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6730-2026-05-29-1612-9769qc","company_id":"6730","company":"常廣","market":"上櫃","industry":"生技醫療","date":"2026-05-29","time":"16:12:20","subject":"公告本公司董事會選任董事長","clause":"第6款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：常廣（6730），2026-05-29 16:12，「公告本公司董事會選任董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6730-2026-05-29-1611-155ao8v","company_id":"6730","company":"常廣","market":"上櫃","industry":"生技醫療","date":"2026-05-29","time":"16:11:49","subject":"公告本公司第三屆薪資報酬委員會任期屆滿","clause":"第6款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：常廣（6730），2026-05-29 16:11，「公告本公司第三屆薪資報酬委員會任期屆滿」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4137-2026-05-29-1611-1urbuv2","company_id":"4137","company":"麗豐-KY","market":"上市","industry":"生技醫療","date":"2026-05-29","time":"16:11:29","subject":"公告本公司訂定除息基準日及本公司發行國內第二次無擔保轉換公司債停止轉換期間相關事宜","clause":"第14款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：麗豐-KY（4137），2026-05-29 16:11，「公告本公司訂定除息基準日及本公司發行國內第二次無擔保轉換公司債停止轉換期間相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6730-2026-05-29-1611-peusgi","company_id":"6730","company":"常廣","market":"上櫃","industry":"生技醫療","date":"2026-05-29","time":"16:11:16","subject":"公告本公司第四屆審計委員會委員","clause":"第6款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：常廣（6730），2026-05-29 16:11，「公告本公司第四屆審計委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6730-2026-05-29-1610-9hj3fk","company_id":"6730","company":"常廣","market":"上櫃","industry":"生技醫療","date":"2026-05-29","time":"16:10:41","subject":"公告本公司115年股東常會決議解除新任董事競業禁止之限制","clause":"第21款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：常廣（6730），2026-05-29 16:10，「公告本公司115年股東常會決議解除新任董事競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4137-2026-05-29-1609-3il1nf","company_id":"4137","company":"麗豐-KY","market":"上市","industry":"生技醫療","date":"2026-05-29","time":"16:09:40","subject":"公告本公司115年度股東常會重要決議事項","clause":"第18款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：麗豐-KY（4137），2026-05-29 16:09，「公告本公司115年度股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6730-2026-05-29-1609-182hwuo","company_id":"6730","company":"常廣","market":"上櫃","industry":"生技醫療","date":"2026-05-29","time":"16:09:32","subject":"公告本公司115年股東常會全面改選董事及獨立董事當選名單","clause":"第6款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：常廣（6730），2026-05-29 16:09，「公告本公司115年股東常會全面改選董事及獨立董事當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6730-2026-05-29-1608-1jb8ii5","company_id":"6730","company":"常廣","market":"上櫃","industry":"生技醫療","date":"2026-05-29","time":"16:08:45","subject":"公告本公司115年股東常會重要決議事項","clause":"第18款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：常廣（6730），2026-05-29 16:08，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4133-2026-05-29-1608-1o19og8","company_id":"4133","company":"亞諾法","market":"上市","industry":"生技醫療","date":"2026-05-29","time":"16:08:19","subject":"本公司董事會推舉Wilber Huang先生續任董事長","clause":"第6款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：亞諾法（4133），2026-05-29 16:08，「本公司董事會推舉Wilber Huang先生續任董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6934-2026-05-29-1606-1jb8ii5","company_id":"6934","company":"心誠鎂","market":"上市","industry":"生技醫療","date":"2026-05-29","time":"16:06:08","subject":"公告本公司115年股東常會重要決議事項","clause":"第18款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：心誠鎂（6934），2026-05-29 16:06，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1789-2026-05-29-1605-qatipn","company_id":"1789","company":"神隆","market":"上市","industry":"生技醫療","date":"2026-05-29","time":"16:05:53","subject":"本公司受邀參加統一證券舉辦之線上法人說明會","clause":"第12款","fact_date":"2026-06-04","cite_as":"公開資訊觀測站重大訊息：神隆（1789），2026-05-29 16:05，「本公司受邀參加統一證券舉辦之線上法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4133-2026-05-29-1604-2siibw","company_id":"4133","company":"亞諾法","market":"上市","industry":"生技醫療","date":"2026-05-29","time":"16:04:01","subject":"公告本公司股東常會決議解除新任董事及其代表人之競業禁止限制案","clause":"第21款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：亞諾法（4133），2026-05-29 16:04，「公告本公司股東常會決議解除新任董事及其代表人之競業禁止限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6918-2026-05-29-1602-1jb8ii5","company_id":"6918","company":"愛派司","market":"上市","industry":"生技醫療","date":"2026-05-29","time":"16:02:27","subject":"公告本公司115年股東常會重要決議事項","clause":"第18款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：愛派司（6918），2026-05-29 16:02，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4133-2026-05-29-1555-1dfr71w","company_id":"4133","company":"亞諾法","market":"上市","industry":"生技醫療","date":"2026-05-29","time":"15:55:00","subject":"公告本公司115年股東常會全面改選第10屆董事當選名單","clause":"第6款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：亞諾法（4133），2026-05-29 15:55，「公告本公司115年股東常會全面改選第10屆董事當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6814-2026-05-29-1554-1pzjlpi","company_id":"6814","company":"路迦生醫","market":"興櫃","industry":"生技醫療","date":"2026-05-29","time":"15:54:05","subject":"公告本公司預估未來三個月現金收支情形及銀行可使用融資額度情形","clause":"第44款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：路迦生醫（6814），2026-05-29 15:54，「公告本公司預估未來三個月現金收支情形及銀行可使用融資額度情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4133-2026-05-29-1551-t851lp","company_id":"4133","company":"亞諾法","market":"上市","industry":"生技醫療","date":"2026-05-29","time":"15:51:58","subject":"公告本公司除息基準日及現金股利發放日","clause":"第14款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：亞諾法（4133），2026-05-29 15:51，「公告本公司除息基準日及現金股利發放日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4194-2026-05-29-1550-1gajc8e","company_id":"4194","company":"禾生技","market":"興櫃","industry":"生技醫療","date":"2026-05-29","time":"15:50:55","subject":"本公司董事會選任董事長","clause":"第6款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：禾生技（4194），2026-05-29 15:50，「本公司董事會選任董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4133-2026-05-29-1544-1jb8ii5","company_id":"4133","company":"亞諾法","market":"上市","industry":"生技醫療","date":"2026-05-29","time":"15:44:59","subject":"公告本公司115年股東常會重要決議事項","clause":"第18款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：亞諾法（4133），2026-05-29 15:44，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6666-2026-05-29-1540-1egfkms","company_id":"6666","company":"羅麗芬-KY","market":"上市","industry":"生技醫療","date":"2026-05-29","time":"15:40:31","subject":"公告本公司董事會通過重要決議","clause":"第51款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：羅麗芬-KY（6666），2026-05-29 15:40，「公告本公司董事會通過重要決議」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6817-2026-05-29-1540-1s3jlig","company_id":"6817","company":"溫士頓","market":"興櫃","industry":"生技醫療","date":"2026-05-29","time":"15:40:21","subject":"公告本公司董事長訂定除息基準日暨現金股利發放日","clause":"第31款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：溫士頓（6817），2026-05-29 15:40，「公告本公司董事長訂定除息基準日暨現金股利發放日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4172-2026-05-29-1540-ln20m1","company_id":"4172","company":"因華","market":"興櫃","industry":"生技醫療","date":"2026-05-29","time":"15:40:20","subject":"公告本公司民國115年股東常會決議解除本公司董事競業禁止之限制案","clause":"第22款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：因華（4172），2026-05-29 15:40，「公告本公司民國115年股東常會決議解除本公司董事競業禁止之限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6666-2026-05-29-1539-2ngh41","company_id":"6666","company":"羅麗芬-KY","market":"上市","industry":"生技醫療","date":"2026-05-29","time":"15:39:31","subject":"公告本公司董事會決議委任第四屆薪資報酬委員會委員","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：羅麗芬-KY（6666），2026-05-29 15:39，「公告本公司董事會決議委任第四屆薪資報酬委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6817-2026-05-29-1539-1r2d1uw","company_id":"6817","company":"溫士頓","market":"興櫃","industry":"生技醫療","date":"2026-05-29","time":"15:39:29","subject":"公告本公司第三屆審計委員會委員","clause":"第6款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：溫士頓（6817），2026-05-29 15:39，「公告本公司第三屆審計委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6817-2026-05-29-1538-1dxch9p","company_id":"6817","company":"溫士頓","market":"興櫃","industry":"生技醫療","date":"2026-05-29","time":"15:38:58","subject":"公告本公司第三屆薪酬委員會委員","clause":"第6款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：溫士頓（6817），2026-05-29 15:38，「公告本公司第三屆薪酬委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6666-2026-05-29-1538-x7m9bg","company_id":"6666","company":"羅麗芬-KY","market":"上市","industry":"生技醫療","date":"2026-05-29","time":"15:38:46","subject":"公告本公司第四屆審計委員會委員及召集人","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：羅麗芬-KY（6666），2026-05-29 15:38，「公告本公司第四屆審計委員會委員及召集人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6817-2026-05-29-1538-1dp3168","company_id":"6817","company":"溫士頓","market":"興櫃","industry":"生技醫療","date":"2026-05-29","time":"15:38:19","subject":"公告本公司115年股東常會通過解除新任董事競業禁止事宜","clause":"第22款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：溫士頓（6817），2026-05-29 15:38，「公告本公司115年股東常會通過解除新任董事競業禁止事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6666-2026-05-29-1537-9769qc","company_id":"6666","company":"羅麗芬-KY","market":"上市","industry":"生技醫療","date":"2026-05-29","time":"15:37:45","subject":"公告本公司董事會選任董事長","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：羅麗芬-KY（6666），2026-05-29 15:37，「公告本公司董事會選任董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6817-2026-05-29-1537-9769qc","company_id":"6817","company":"溫士頓","market":"興櫃","industry":"生技醫療","date":"2026-05-29","time":"15:37:21","subject":"公告本公司董事會選任董事長","clause":"第6款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：溫士頓（6817），2026-05-29 15:37，「公告本公司董事會選任董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6666-2026-05-29-1536-ukibj","company_id":"6666","company":"羅麗芬-KY","market":"上市","industry":"生技醫療","date":"2026-05-29","time":"15:36:50","subject":"公告本公司股東常會決議解除董事競業禁止限制案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：羅麗芬-KY（6666），2026-05-29 15:36，「公告本公司股東常會決議解除董事競業禁止限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6817-2026-05-29-1536-1gga16","company_id":"6817","company":"溫士頓","market":"興櫃","industry":"生技醫療","date":"2026-05-29","time":"15:36:44","subject":"公告本公司115年股東常會董事(含獨立董事)全面改選當選名單","clause":"第6款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：溫士頓（6817），2026-05-29 15:36，「公告本公司115年股東常會董事(含獨立董事)全面改選當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6817-2026-05-29-1535-1jb8ii5","company_id":"6817","company":"溫士頓","market":"興櫃","industry":"生技醫療","date":"2026-05-29","time":"15:35:16","subject":"公告本公司115年股東常會重要決議事項","clause":"第15款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：溫士頓（6817），2026-05-29 15:35，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6666-2026-05-29-1534-xoimf2","company_id":"6666","company":"羅麗芬-KY","market":"上市","industry":"生技醫療","date":"2026-05-29","time":"15:34:53","subject":"公告本公司2026年股東常會改選第五屆董事及獨立董事","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：羅麗芬-KY（6666），2026-05-29 15:34，「公告本公司2026年股東常會改選第五屆董事及獨立董事」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4172-2026-05-29-1533-1kxwrjh","company_id":"4172","company":"因華","market":"興櫃","industry":"生技醫療","date":"2026-05-29","time":"15:33:16","subject":"公告本公司民國115年股東常會重要決議事項","clause":"第15款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：因華（4172），2026-05-29 15:33，「公告本公司民國115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6666-2026-05-29-1532-cobe39","company_id":"6666","company":"羅麗芬-KY","market":"上市","industry":"生技醫療","date":"2026-05-29","time":"15:32:56","subject":"公告本公司115年股東常會重要決議","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：羅麗芬-KY（6666），2026-05-29 15:32，「公告本公司115年股東常會重要決議」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6535-2026-05-29-1531-1b6p9pm","company_id":"6535","company":"順藥","market":"上櫃","industry":"生技醫療","date":"2026-05-29","time":"15:31:22","subject":"公告本公司LT3001急性缺血性腦中風新藥取得美國給藥方法專利核准","clause":"第53款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：順藥（6535），2026-05-29 15:31，「公告本公司LT3001急性缺血性腦中風新藥取得美國給藥方法專利核准」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7759-2026-05-29-1512-cobe39","company_id":"7759","company":"視航生醫","market":"興櫃","industry":"生技醫療","date":"2026-05-29","time":"15:12:01","subject":"公告本公司115年股東常會重要決議","clause":"第15款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：視航生醫（7759），2026-05-29 15:12，「公告本公司115年股東常會重要決議」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6499-2026-05-29-1504-1s3tpuy","company_id":"6499","company":"益安","market":"上櫃","industry":"生技醫療","date":"2026-05-29","time":"15:04:21","subject":"代重要子公司意能生技股份有限公司公告115年股東常會重要決議事項","clause":"第18款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：益安（6499），2026-05-29 15:04，「代重要子公司意能生技股份有限公司公告115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4164-2026-05-29-1501-19ws7nb","company_id":"4164","company":"承業醫","market":"上市","industry":"生技醫療","date":"2026-05-29","time":"15:01:20","subject":"公告本公司除息基準日","clause":"第14款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：承業醫（4164），2026-05-29 15:01，「公告本公司除息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6499-2026-05-29-1456-zu58m","company_id":"6499","company":"益安","market":"上櫃","industry":"生技醫療","date":"2026-05-29","time":"14:56:53","subject":"代重要子公司益興生醫股份有限公司公告2026年股東常會重要決議事項","clause":"第18款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：益安（6499），2026-05-29 14:56，「代重要子公司益興生醫股份有限公司公告2026年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4175-2026-05-29-1438-1s1tpxi","company_id":"4175","company":"杏一","market":"上櫃","industry":"生技醫療","date":"2026-05-29","time":"14:38:44","subject":"公告本公司第二屆永續發展委員會委員名單","clause":"第6款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：杏一（4175），2026-05-29 14:38，「公告本公司第二屆永續發展委員會委員名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6794-2026-05-29-1412-loqbyv","company_id":"6794","company":"向榮生技","market":"上市","industry":"生技醫療","date":"2026-05-29","time":"14:12:42","subject":"本公司脂肪幹細胞新藥ELIXCYTE治療膝骨關節炎(Knee Osteoarthritis)之人體臨床試驗，向衛生福利部提出申請臨床試驗設計變更。","clause":"第10款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：向榮生技（6794），2026-05-29 14:12，「本公司脂肪幹細胞新藥ELIXCYTE治療膝骨關節炎(Knee Osteoarthritis)之人體臨床試驗，向衛生福利部」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4175-2026-05-29-1411-nhz13a","company_id":"4175","company":"杏一","market":"上櫃","industry":"生技醫療","date":"2026-05-29","time":"14:11:45","subject":"公告本公司第二屆提名委員會委員名單","clause":"第6款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：杏一（4175），2026-05-29 14:11，「公告本公司第二屆提名委員會委員名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4175-2026-05-29-1411-1mh9fmm","company_id":"4175","company":"杏一","market":"上櫃","industry":"生技醫療","date":"2026-05-29","time":"14:11:25","subject":"公告本公司第六屆薪資報酬委員會委員名單","clause":"第6款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：杏一（4175），2026-05-29 14:11，「公告本公司第六屆薪資報酬委員會委員名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4175-2026-05-29-1411-7wkv7c","company_id":"4175","company":"杏一","market":"上櫃","industry":"生技醫療","date":"2026-05-29","time":"14:11:01","subject":"公告本公司第五屆審計委員會委員名單","clause":"第6款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：杏一（4175），2026-05-29 14:11，「公告本公司第五屆審計委員會委員名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4175-2026-05-29-1410-9769qc","company_id":"4175","company":"杏一","market":"上櫃","industry":"生技醫療","date":"2026-05-29","time":"14:10:11","subject":"公告本公司董事會選任董事長","clause":"第6款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：杏一（4175），2026-05-29 14:10，「公告本公司董事會選任董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4175-2026-05-29-1409-1a5r2zi","company_id":"4175","company":"杏一","market":"上櫃","industry":"生技醫療","date":"2026-05-29","time":"14:09:40","subject":"公告本公司115年股東常會通過解除新任董事及其代表人競業禁止案","clause":"第21款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：杏一（4175），2026-05-29 14:09，「公告本公司115年股東常會通過解除新任董事及其代表人競業禁止案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4175-2026-05-29-1408-1vnw0hn","company_id":"4175","company":"杏一","market":"上櫃","industry":"生技醫療","date":"2026-05-29","time":"14:08:28","subject":"公告115年股東常會全面改選董事(含獨立董事)當選名單暨董事變動達三分之一","clause":"第6款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：杏一（4175），2026-05-29 14:08，「公告115年股東常會全面改選董事(含獨立董事)當選名單暨董事變動達三分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6242-2026-05-29-1408-ya1oy7","company_id":"6242","company":"立康","market":"上櫃","industry":"生技醫療","date":"2026-05-29","time":"14:08:00","subject":"公告本公司董事長訂定除息基準日相關事宜","clause":"第14款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：立康（6242），2026-05-29 14:08，「公告本公司董事長訂定除息基準日相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4175-2026-05-29-1406-1jb8ii5","company_id":"4175","company":"杏一","market":"上櫃","industry":"生技醫療","date":"2026-05-29","time":"14:06:52","subject":"公告本公司115年股東常會重要決議事項","clause":"第18款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：杏一（4175），2026-05-29 14:06，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6612-2026-05-29-1351-1ljalkc","company_id":"6612","company":"奈米醫材","market":"上櫃","industry":"生技醫療","date":"2026-05-29","time":"13:51:01","subject":"代重要子公司詠豪科技股份有限公司公告115年股東會重要決議事項","clause":"第18款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：奈米醫材（6612），2026-05-29 13:51，「代重要子公司詠豪科技股份有限公司公告115年股東會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6589-2026-05-29-1330-p1h1y8","company_id":"6589","company":"台康生技","market":"上市","industry":"生技醫療","date":"2026-05-29","time":"13:30:24","subject":"本公司註銷限制員工權利新股減資變更登記完成","clause":"第36款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：台康生技（6589），2026-05-29 13:30，「本公司註銷限制員工權利新股減資變更登記完成」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6677-2026-05-29-1327-1jb8ii5","company_id":"6677","company":"瑩碩生技","market":"興櫃","industry":"生技醫療","date":"2026-05-29","time":"13:27:41","subject":"公告本公司115年股東常會重要決議事項","clause":"第15款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：瑩碩生技（6677），2026-05-29 13:27，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6677-2026-05-29-1320-1jb8ii5","company_id":"6677","company":"瑩碩生技","market":"興櫃","industry":"生技醫療","date":"2026-05-29","time":"13:20:29","subject":"公告本公司115年股東常會重要決議事項","clause":"第15款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：瑩碩生技（6677），2026-05-29 13:20，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6589-2026-05-29-1213-f0kx75","company_id":"6589","company":"台康生技","market":"上市","industry":"生技醫療","date":"2026-05-29","time":"12:13:34","subject":"本公司股東會決議解除董事及其代表人競業禁止之限制","clause":"第21款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：台康生技（6589），2026-05-29 12:13，「本公司股東會決議解除董事及其代表人競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6589-2026-05-29-1213-1k64km4","company_id":"6589","company":"台康生技","market":"上市","industry":"生技醫療","date":"2026-05-29","time":"12:13:22","subject":"台康生技公司股東常會重要決議","clause":"第18款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：台康生技（6589），2026-05-29 12:13，「台康生技公司股東常會重要決議」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6929-2026-05-29-1125-1jb8ii5","company_id":"6929","company":"佑全","market":"上櫃","industry":"生技醫療","date":"2026-05-29","time":"11:25:30","subject":"公告本公司115年股東常會重要決議事項","clause":"第18款","fact_date":"2026-05-29","cite_as":"公開資訊觀測站重大訊息：佑全（6929），2026-05-29 11:25，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}